Association of Super-extended Lymphadenectomy at Radical Cystectomy with Perioperative Complications and Re-hospitalization

Overview

Journal World J Urol

Specialty Urology

Date 2019 Apr 22

PMID 31006052

Citations 5

Authors

David DAndrea

Mohammad Abufaraj

Francesco Soria

Kilian Gust

Andrea Haitel

Pierre I Krakiewicz

Shahrokh F Shariat

Affiliations

Soon will be listed here.

Abstract

Purpose: We performed a retrospective analysis of patients treated with radical cystectomy and lymphadenectomy (LAD) for bladder cancer to assess the differential association of the extent of LAD with perioperative complications and re-hospitalization.

Materials And Methods: LAD templates were defined as limited (lLAD = external, internal iliac and obturator), extended (eLAD = up to crossing of ureter and presacral lymph nodes), and super-extended (sLAD = up to the inferior mesenteric artery). Logistic regression models investigated the association of LAD templates with intraoperative, 30- and 30-90-day postoperative complications, as well as re-hospitalizations within 30 and 30-90 days.

Results: A total of 284 patients were available for analysis. sLAD led to a higher lymph-node yield (median 39 vs 13 for lLAD and 31 for eLAD, p < 0.05) and N2/N3 status compared to lLAD and eLAD (p = 0.04). sLAD was associated with a blood loss of > 500 ml (OR 1.3, 95% CI 1.08-1.49, p = 0.003) but not with intraoperative transfusion, operation time, or length of hospital stay (p > 0.05). Overall, 11 (4%) patients were readmitted within 30 days and 50 (17.6%) within 30-90 days. The 30- and 30-90-day mortality rates were 2.8% and 1.4%, respectively. On logistic regression, LAD template was not associated with postoperative complications or re-hospitalization rates.

Conclusions: sLAD leads to higher lymph-node yield and N2/N3 rate but not to higher complication rate compared to lLAD and eLAD. With the advent of novel adjuvant systemic therapies, precise nodal staging will have a crucial role in patients counseling and clinical decision making.

Citing Articles

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.

Ji H, Hu C, Yang X, Liu Y, Ji G, Ge S Signal Transduct Target Ther. 2023; 8(1):367.

PMID: 37752146 PMC: 10522642. DOI: 10.1038/s41392-023-01576-4.

Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations.

Lee H, Kwon W, Nguyen L, Phan D, Seo H Cancers (Basel). 2023; 15(4).

PMID: 36831665 PMC: 9953905. DOI: 10.3390/cancers15041323.

Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis.

Qi W, Zhong M, Jiang N, Zhou Y, Lv G, Li R Front Oncol. 2022; 12:986150.

PMID: 36505883 PMC: 9732561. DOI: 10.3389/fonc.2022.986150.

Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.

Konig F, Pradere B, Grossmann N, Quhal F, Rajwa P, Laukhtina E Transl Cancer Res. 2022; 11(4):908-917.

PMID: 35571640 PMC: 9091037. DOI: 10.21037/tcr-21-1116.

Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes.

Wang Y, Wu J, Dai B, Shen Y, Ma C, Ye D World J Surg Oncol. 2019; 17(1):225.

PMID: 31864368 PMC: 6925870. DOI: 10.1186/s12957-019-1759-5.

References

Zehnder P, Studer U, Skinner E, Dorin R, Cai J, Roth B . Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011; 186(4):1261-8. DOI: 10.1016/j.juro.2011.06.004. View

Jensen J, Ulhoi B, Jensen K . Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol. 2011; 19(1):39-47. DOI: 10.1111/j.1442-2042.2011.02887.x. View

Joice G, Chappidi M, Patel H, Kates M, Sopko N, Stimson C . Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter?. BJU Int. 2018; 122(6):1016-1024. DOI: 10.1111/bju.14448. View

Isbarn H, Jeldres C, Zini L, Perrotte P, Baillargeon-Gagne S, Capitanio U . A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol. 2009; 182(1):70-7. DOI: 10.1016/j.juro.2009.02.120. View

Abdollah F, Sun M, Schmitges J, Djahangirian O, Tian Z, Jeldres C . Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU Int. 2011; 109(8):1147-54. DOI: 10.1111/j.1464-410X.2011.10482.x. View

Shabsigh A, Korets R, Vora K, Brooks C, Cronin A, Savage C . Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2008; 55(1):164-74. DOI: 10.1016/j.eururo.2008.07.031. View

Jensen J, Ulhoi B, Jensen K . Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery. BJU Int. 2009; 106(2):199-205. DOI: 10.1111/j.1464-410X.2009.09118.x. View

Leissner J, Ghoneim M, Abol-Enein H, Thuroff J, Franzaring L, Fisch M . Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2003; 171(1):139-44. DOI: 10.1097/01.ju.0000102302.26806.fb. View

Grossman H, Natale R, Tangen C, Speights V, Vogelzang N, Trump D . Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003; 349(9):859-66. DOI: 10.1056/NEJMoa022148. View

10.

Dorin R, Daneshmand S, Eisenberg M, Chandrasoma S, Cai J, Miranda G . Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol. 2011; 60(5):946-52. DOI: 10.1016/j.eururo.2011.07.012. View

11.

Rink M, Fajkovic H, Cha E, Gupta A, Karakiewicz P, Chun F . Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol. 2012; 61(4):854-5. DOI: 10.1016/j.eururo.2011.12.055. View

12.

Azhar R, Bochner B, Catto J, Goh A, Kelly J, Patel H . Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes, Key Elements, and Research Needs. Eur Urol. 2016; 70(1):176-187. PMC: 5514421. DOI: 10.1016/j.eururo.2016.02.051. View

13.

Stimson C, Chang S, Barocas D, Humphrey J, Patel S, Clark P . Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol. 2010; 184(4):1296-300. DOI: 10.1016/j.juro.2010.06.007. View

14.

Bruins H, Veskimae E, Hernandez V, Imamura M, Neuberger M, Dahm P . The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Eur Urol. 2014; 66(6):1065-77. DOI: 10.1016/j.eururo.2014.05.031. View

15.

Dindo D, Demartines N, Clavien P . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13. PMC: 1360123. DOI: 10.1097/01.sla.0000133083.54934.ae. View

16.

Brossner C, Pycha A, Toth A, Mian C, Kuber W . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU Int. 2003; 93(1):64-6. DOI: 10.1111/j.1464-410x.2004.04557.x. View

17.

Gschwend J, Heck M, Lehmann J, Rubben H, Albers P, Wolff J . Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol. 2018; 75(4):604-611. DOI: 10.1016/j.eururo.2018.09.047. View

18.

Stitzenberg K, Chang Y, Smith A, Nielsen M . Exploring the burden of inpatient readmissions after major cancer surgery. J Clin Oncol. 2014; 33(5):455-64. PMC: 4314594. DOI: 10.1200/JCO.2014.55.5938. View

19.

Woldu S, Sanli O, Clinton T, Lotan Y . Validating the predictors of outcomes after radical cystectomy for bladder cancer. Cancer. 2018; 125(2):223-231. DOI: 10.1002/cncr.31799. View

20.

Witjes J, Lebret T, Comperat E, Cowan N, De Santis M, Bruins H . Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol. 2016; 71(3):462-475. DOI: 10.1016/j.eururo.2016.06.020. View